Status:
COMPLETED
Dose-Response Curve: Interventions to Prevent and Treat Radiodermatitis
Lead Sponsor:
University of Brasilia
Collaborating Sponsors:
University of Washington
Conditions:
Radiodermatitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Dose response curve to define the security and tolerable dose to be used for prevention and treatment of radiodermatitis in patients with breast or head and neck cancer.
Detailed Description
The study is being conducted in Center for High Complexity Oncology (CACON) located at the University Hospital of Brasília (HUB). Has as its target population subjects diagnosed with breast and head a...
Eligibility Criteria
Inclusion
- Being an adult, over the age of 18 years old
- Owning diagnosis of breast or head and neck cancer
- Being first referred to the radiotherapy protocol
- Have absence of radiodermatitis and integrates skin to start radiotherapy
- Not have presented anticipated reaction of hypersensitivity to chamomile or any plant of the family Asteraceae or Compositae or urea.
- Demonstrate conditions to continue the intervention in their home environment when needed.
Exclusion
- Medical prescription for the procedure of data collection, some kind of intervention to prevent radiodermatitis.
Key Trial Info
Start Date :
February 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT02249884
Start Date
February 1 2014
End Date
November 1 2015
Last Update
December 2 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Brasília
Brasília, Federal District, Brazil